Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-068-2013

Drug recall · December 5, 2012

Arranon recall

Why: Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06

Lots / codes

Lot # C536707 Exp 02/14, C538830 Exp.02/14, C533169 Exp. 02/14

Quantity
1,319 vials
Company
GlaxoSmithKline, LLC., Zebulon, NC
Distribution
Nationwide
Initiated
October 8, 2012 · Voluntary: Firm initiated
Classified
November 27, 2012
Reported
December 5, 2012
Ended
September 11, 2014
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Nelarabine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.